- Report
- August 2022
- 132 Pages
Middle East, Africa
From €1327EUR$1,500USD£1,145GBP
- Report
- January 2024
- 230 Pages
Global
From €3980EUR$4,500USD£3,436GBP
- Report
- August 2023
- 180 Pages
Global
From €3316EUR$3,750USD£2,863GBP
- Book
- June 2020
- 198 Pages
- Report
- November 2021
- 545 Pages
Global
From €3537EUR$4,000USD£3,054GBP
- Report
- November 2021
- 270 Pages
Global
From €2211EUR$2,500USD£1,909GBP
- Report
- November 2021
- 802 Pages
Global
From €4422EUR$5,000USD£3,818GBP
- Report
- November 2021
- 1184 Pages
Global
From €5306EUR$6,000USD£4,581GBP
- Report
- November 2021
- 1165 Pages
Global
From €5306EUR$6,000USD£4,581GBP
- Book
- November 2024
- 464 Pages
- Book
- December 2023
- 560 Pages
- Book
- August 2021
- 528 Pages
- Book
- February 2021
- 544 Pages
- Book
- December 2020
- 432 Pages
- Book
- March 2019
- 348 Pages
- Book
- May 2013
- 384 Pages
- Book
- September 2023
- 640 Pages
- Book
- July 2019
- 480 Pages

The Transcriptome market is a subset of the biotechnology industry that focuses on the study of the transcriptome, which is the set of all RNA molecules in a cell. This includes messenger RNA (mRNA), ribosomal RNA (rRNA), transfer RNA (tRNA), and other non-coding RNA molecules. Transcriptome analysis is used to study gene expression, gene regulation, and other aspects of gene function. It is also used to identify novel genes and to study the effects of genetic mutations.
The Transcriptome market is driven by the need for better understanding of gene expression and regulation, as well as the development of new treatments for diseases. Companies in this market are developing technologies and products to enable researchers to better understand the transcriptome and its role in health and disease.
Some companies in the Transcriptome market include Illumina, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, and Qiagen. Show Less Read more